MILENA BONILLA: Open Payments
NPI 1477702892 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,305 in 123 payments from 17 companies in 2025. Trend: 2023 $3,469 · 2024 $2,920 · 2025 $3,305
Food & beverage: $3,215Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $521 |
| UCB, Inc. | 12 | $362 |
| GENZYME CORPORATION | 10 | $361 |
| Incyte Corporation | 13 | $354 |
| ABBVIE INC. | 12 | $291 |
| LEO Pharma Inc. | 7 | $283 |
| PFIZER INC. | 14 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $226 |
| Novartis Pharmaceuticals Corporation | 8 | $185 |
| Regeneron Healthcare Solutions, Inc. | 8 | $172 |
Products named: DUPIXENT, TREMFYA, Bimzelx, OPZELURA, ANZUPGO, CIBINQO, RINVOQ, Leqselvi.
Industry payments across NY — which companies pay providers there.
